Startups
SABCS is an international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.
Overview
Location
United States, Texas, San Antonio
Employees
1-10
Phone
+1 210-450-1550
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 24, 2026 | DualityBio (9606.HK) Announces 2025 Annual Results | HONG KONG, March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" or the "Company"), a leading global clinical-stage innovative biop... |
| Aug 28, 2025 | Incyclix Bio: $11.25 Million Series B Extension Secured For Treating Resistant Cancer | Incyclix Bio is a company working on advanced cancer treatments. They are developing a new drug called INX-315, a potent and selective inhibitor targeting CDK2, a protein that regulates the cell cycle. This drug aims to treat severe and res... |
| Mar 26, 2025 | BCYW Foundation Highlights Advances in Young Women's Breast Cancer from the 2024 San Antonio Breast Cancer Symposium | Left, An Image Displaying the BCYW Foundation's Mission. Right,The Theme of the BCYW Foundation's International Meeting, Hosted in Partnership with CUF Portugal. An Image Displaying the Core BCYWF Awareness Message. The BCYW Found... |
| Nov 26, 2024 | Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC) | Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC. Updated results of elacestrant in combination with abemaciclib show favorable efficacy regardless of the ESR1 mutati... |
| Nov 20, 2024 | VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract for San Antonio Breast Cancer Symposium® | CAMBRIDGE, MA, UNITED STATES, November 20, 2024 /EINPresswire.com/ -- VRise Therapeutics Inc. will be presenting groundbreaking findings at the upcoming San Antonio Breast Cancer Symposium®, set to take place on December 10-13 in San Antoni... |
| Nov 30, 2023 | Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS | MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-ta... |
| Dec 8, 2022 | POSITIVE study shows: young women with breast cancer can safely have a baby | POSITIVE study shows: young women with breast cancer can safely have a baby Thu, Dec 08, 2022 15:54 CET Report this content Pausing endocrine treatment to try to get pregnant can be done without additional risk of recurrence in the short te... |
| Nov 22, 2022 | AmunBio to Present Scientific Data for AMUN-003 at the 2022 San Antonio Breast Cancer Symposium (SABCS) | Pre-clinical data, to be presented at SABCS, shows that AMUN-003 demonstrated single agent safety and efficacy in TNBC. The same model shows how combination therapy with immune Checkpoint Inhibitors synergizes with the AMUN-003, resulting i... |
| Dec 13, 2021 | Greenwich LifeSciences : Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology - Form 8-K | Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology ● Identifying GP2 specific T cell immune response at baseline prior to treatment with GP2 ... |
Show more
Reviews 0
FAQ about San Antonio Breast Cancer Symposium
What has the press written about San Antonio Breast Cancer Symposium?
Parsers VC has collected 15 articles mentioning San Antonio Breast Cancer Symposium, among them “DualityBio (9606.HK) Announces 2025 Annual Results” (Mar 24, 2026) and “Incyclix Bio: $11.25 Million Series B Extension Secured For Treating Resistant Cancer” (Aug 28, 2025).
Is San Antonio Breast Cancer Symposium still active?
Yes, San Antonio Breast Cancer Symposium is active; its latest activity on Parsers VC dates from Nov 3, 2026.